CliffBio
small molecule

TRIPHASIL-21

ETHINYL ESTRADIOL; LEVONORGESTREL

Loss of exclusivity—loss of exclusivity
CompanyWyeth →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRIPHASIL-21
Active ingredientETHINYL ESTRADIOL; LEVONORGESTREL
Strength0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET
RouteORAL-21
ModalitySmall molecule
FDA approvalNovember 1984
Marketing statusDISCN

More from Wyeth

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.